All News

The Drug Topics® team rounded up some of our top-read articles from the last year.

Here’s the last roundup of the latest coronavirus-related news in 2020.

MJH Life Sciences™ COVID-19 Coalition will be hosting its next live webinar event on the disproportionate impact of COVID-19 among racial and ethnic minority groups.

The FDA approved ansuvimab-zykl (Ebanga; Ridgeback Biotherapeutics) for the treatment of Zaire ebolavirus (Ebolavirus) infection in adults and children.

Pharmacists can now access this on-demand webcast for insights on how to optimize their business through in-store experience, marketing, managed care, and business performance.

The FDA has authorized the Moderna mRNA vaccine for emergency use, making it the second vaccine for COVID-19.

Extra vaccine multidose vials may boost the country’s supply by millions of doses.

Here’s a roundup of the latest coronavirus-related news.

US prescription opioid use dropped 60% from its peak volume in 2011, according to a new report from the IQVIA Institute for Human Data Science.

This week, members of the MJH Life Sciences COVID-19 Coalition shared insights on the latest pandemic news, including long-term health consequences, vaccine hesitancy, and new recommendations.

The program is designed to provide immunization administration training to hundreds of thousands of pharmacy technicians within weeks.

The FDA has granted emergency use authorization (EUA) to the Pfizer/BioNTech COVID-19 vaccine.

Here’s a roundup of the latest coronavirus-related news:

The National Association of Chain Drug Stores and the National Forum for Heart Disease & Stroke Prevention released a video urging Americans to receive flu vaccinations.

The FDA is not required to follow the committee's advice, but it is expected to do so.

SCOTUS' decision upholds an Arkansas law regulating PBMs’ drug reimbursement rates.

Award winning actor Tom Hanks addressed pharmacists during the ASHP Midyear 2020 Clinical Meeting & Exhibition.

Each year, Drug Topics® surveys pharmacists on important workplace issues—from compensation encompassing salary, wages, and raises to stress levels and overall job satisfaction.

Here’s a roundup of the latest coronavirus-related news.

CVS Health will pilot the administration of a limited supply of the monoclonal antibody therapy bamlanivimab to eligible patients at home or in long-term care facilities.

A survey conducted by the American Pharmacists Association asked pharmacists if they were ready to receive and administer COVID-19 vaccines.

The first doses of the mRNA COVID-19 vaccine will be delivered in the UK in the next few days, Pfizer announced.

The clinics integrate pharmacists as critical members of VillageMD’s physician-led, multidisciplinary team.

Here’s a preview of the featured content to watch for this week on Drug Topics®.

Moderna reported an efficacy rate of 94.1% for its COVID-19 vaccine based on the primary efficacy analysis.

A recent study showed “alarming” rates of reported loneliness, anxiety, depression, and substance use in young adults during COVID-19.

Here’s a roundup of this week’s coronavirus-related news.

As coronavirus disease 2019 (COVID-19) cases rise across the country, members of the MJH Life Sciences COVID-19 Coalition shared their perspectives on pandemic containment efforts.

Lumasiran (Oxlumo; Alnylam Pharmaceuticals) is the first drug approved for the treatment of primary hyperoxaluria type 1, a rare genetic disorder.

The new model will test a new way to lower increasing drug prices for patients paying for drugs under Medicare Part B.